Century Therapeutics, a startup founded by Versant Ventures, launched this morning with $250 million in hand and a focus on developing induced pluripotent stem cell- (iPSC) based therapies for the treatment of hematologic and solid malignancies.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,